Iron and infection

Kidney International, Supplement

Volumn 55, Issue 69, 1999, Pages

  Patruta, Sanda I ^a   Hörl, Walter H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bacteria; Dialysis; Erythropoietin; Hydroxyl radicals; Malnutrition; Uremic toxin

Indexed keywords

ERYTHROPOIETIN; IRON; HYDROXYL RADICAL;

ANEMIA; B LYMPHOCYTE; BACTERIAL VIRULENCE; DIALYSIS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; IRON METABOLISM; IRON STORAGE; IRON THERAPY; IRON TRANSPORT; KIDNEY FAILURE; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; CHRONIC KIDNEY FAILURE; IMMUNOLOGY; METABOLISM;

ANEMIA; ANIMALS; B-LYMPHOCYTES; HUMANS; HYDROXYL RADICAL; INFECTION; IRON; KIDNEY FAILURE, CHRONIC; PHAGOCYTES; T-LYMPHOCYTES;

EID: 0032934421     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.055suppl.69125.x     Document Type: Review

References (75)

1. MACDOUGALL IC: Poor response to erythropoietin: Practical guidelines on investigation and management. Nephrol Dial Transplant 10:607-614, 1995
2. SUNDER-PLASSMANN G, HÖRL WH: Erythropoietin and iron. Clin Nephrol 47:141-157, 1997
3. KOOISTRA MP, VAN ES A, STRUYVENBERG A, MARX JJM: Low iron absorption in erythropoietin-treated haemodialysis patients. (abstract) J Am Soc Nephrol 6:543, 1995
4. DOMOTO DT, MARTIN KJ: Failure of CAPD patients to respond to an oral iron absorption test. Adv Pent Dial 8:102-104, 1992
5. SUNDER-PLASSMANN G. HÖRL WH: Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 10:2070-2076, 1995
6. FISHBANE S, FREI GL, MAESAKA J: Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 26:41-46, 1995
7. MACDOUGALL IC, TUCKER B, THOMPSON J, TOMSON CRV, BAKER LRI, RAINE AEG: A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 50:1694-1699, 1996
8. KEMP JD: The role of iron and iron binding proteins in lymphocyte physiology and pathology. J Clin Immunol 13:81-92, 1993
9. KÜHN LC: Control of cellular iron transport and storage at the molecular level, in Iron Nutrition in Health and Disease, edited by HALLBERG L, ASP GA, New York, John Libbey & Company, 1996, pp 17-29
10. MILLER K, SHIPMAN M, TROWBRIDGE IS, HOPKINS CR: Transferrin receptors promote the formation of clathrin lattices. Cell 65:621-632, 1991
11. BALI PK, ZAK O, AISEN P: A new role for the transferrin receptor in the release of iron from transferrin. Biochemistry 30:324-328, 1991
12. BAKER E, MORGAN EH: Iron transport, in Iron Metabolism in Health and Disease, edited by BROCK JH, HALLIDEAY JW, PIPPARD MJ, POWELL LW, London, W.B. Saunders, 1994, pp 63-95
13. NUNEZ MT, GAETE V, WATKINS JA, GLASS J: Mobilization of iron from endocytic vesicles: The effects of acidification and reduction. J Biol Chem 265:6688-6692, 1990
14. KLAUSNER RD, ROUAULT TA, HARFORD JB: Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 72:19-28, 1993
15. BOMFORD AB, MUNRO HN: Ferritin gene expression in health and malignancy. Pathobiology 60:10-18, 1992
16. FARGION S, FRACANZANI AL, CISLAGHI V, LEVI S, CAPPELLINI MD, FIORELLI G: Characteristics of the membrane receptor for human H-ferritin. Curr Stud Hematol Blood Transfus 58:164-170, 1991
17. HARFORD JB, KLAUSNER RD: Coordinate post-transcriptional regulation of ferritin and transferrin receptor expression: The role of regulated RNA-protein interaction. Enzyme 44:28-41, 1990
18. MUNRO HN: Iron regulation of ferritin gene expression. J Cell Biochem 44:107-115, 1990
19. MASSON PL, HEREMANS JF, SCHONNE E: Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 130:643-658, 1969
20. WEINBERG ED: Iron depletion: A defense against intracellular infection and neoplasia. Life Sci 50:1289-1297, 1992
21. PAYNE SM: Iron and virulence in the family Enterobacteriaceae. Crit Rev Microbiol 16:81-111, 1988
22. HERSHKO CH: Iron and infection, in Iron Nutrition in Health and Disease, edited by HALLBERG L, ASP GA, New York, John Libbey & Company, 1996, pp 231-238
23. SUSSMAN M: Iron and infection, in Iron in Biochemistry and Medicine, edited by JACOBS A, WORWOOD M, New York, Academic Press, 1974, pp 649-679
24. ANG Ö, GÜNGÖR M, ARICIOGLU F, INANC D, SAGDUYU H, UYSAL V, KÜCÜKER M: The effect of parenteral iron administration on the development of Staphylococcus aureus-induced experimental pyelonephritis in rats. Int J Exp Pathol 71:507-511, 1990
25. VADILLO M, CORBELLA X, PAC V, FERNANDEZ-VILADRICH P, PUJOL R: Multiple liver abscesses due to Yersinia enterocolitica discloses primary hemochromatosis: Three case reports and review. Clin Infect Dis 18:938-941, 1994
26. GREEN NS: Yersinia infections in patients with homozygous betathalassemia associated with iron overload and its treatment. Pediatr Hematol Oncol 9:247-254, 1992
27. MAZZOLENI G, DE SA D, GATELY J, RIDDELL RH: Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy. Dig Dis Sci 36:1154-1160, 1991
28. DEUGNIER Y, BATTISTELLI D, JOUANOLLE H, GUYADER D, GUEGUEN M, LORÉAL O, JACQUELINET C, BOUREL M, BRISSOT P: Hepatitis B virus infection markers in genetic haemochromatosis: A study of 272 patients. J Hepatol 13:286-290, 1991
29. BONKOVSKY HL, BANNER BF, ROTHMAN AL: Iron and chronic viral hepatitis. Hepatology 25:759-768, 1997
30. FUJIHARA T, HAYASHI K: Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch Virol 140:1469-1472, 1995
31. HARMSEN MC, SWART PJ, DE BÉTHUNE MP, PAUWELS R, DE CLERCQ E, THE TH, MEIJER DKF: Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 172:380-388, 1995
32. ELLISON RT III, GIEHL TJ: Killing of Gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 88:1080-1091, 1991
33. KLUGER MJ, BULLEN JJ: Clinical and physiological aspects, in Iron and Infection, edited by KRUGER MJ, BULLEN JJ, New York, John Wiley and Sons, 1987, pp 243-282
34. KADIISKA MB, BURKITT MJ, XIANG QH, MASON RP: Iron supplementation generates hydroxyl radical in vivo: An ESR spin-trapping investigation. J Clin Invest 96:1653-1657, 1995
35. HALLIWELL B: Iron and damage to biomolecules, in Iron and Human Disease, edited by LAUFER RB, Boca Raton, CRC Press, 1992, pp 209-236
36. BURKITT MJ, MASON RP: Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: An ESR spin-trapping investigation. Proc Natl Acad Sci USA 88:8440-8444, 1991
37. PRASAD AN, PRASAD C: Iron deficiency: Non-hematological manifestations. Prog Food Nutr Sci 15:255-283, 1991
38. BROCK JH, MAINOU-FOWLER T: The role of iron and transferrin in lymphocyte transformation. Immunol Today 4:347-351, 1983
39. GYGAX M, HIRNI H, ZWAHLEN R, LAZARY S, BLUM JW: Immune functions of veal calves fed low amounts of iron. Zentralbl Veterinarmed [A] 40:345-358, 1993
40. WALTER T, ARREDONDO S, AREVALO M, STEKEL A: Effect of iron therapy on phagocytosis and bacterial activity in neutrophils of iron-deficient infants. Am J Clin Nutr 44:877-882, 1986
41. MURAKAWA H, BLAND CE, WILLIS WT, DALLMAN PR: Iron deficiency and neutrophil function: Different rates of correction of the depressions in oxidative burst and myeloperoxidase activity after iron treatment. Blood 69:1464-1468, 1987
42. KONIJN AM, HERSHKO C: Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release. Brit Haematol 37:7-16, 1977
43. FAHMY M, YOUNG SP: Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: Changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J 296:175-181, 1993
44. BYRD TF, HORWTTZ MA: Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophilia by limiting the availability of iron. J Clin Invest 83:1457-1465, 1989
45. LANE TE, WU-HSIEH BA, HOWARD DH: Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immunol 59:2274-2278, 1991
46. LANCASTER JR, HIBBS JB: EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci USA 87:1223-1227, 1990
47. BARNEWALL RE, RIKIHISA Y: Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron transferrin. Infect Immunol 62:4804-4810, 1994
48. SEIFERT A, VON HERRATH D, SCHAEFES K: Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis. Q J Med 65:1015-1024, 1987
49. BOELAERT JR, VAN LANDUYT HW, VALCKE YJ, CANTINIEAUX B, LORNOVY WF, VANHERWEGHEM J, MOEILLON P, VANDEPITTE JM: The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients. J Infect Dis 156:384-387, 1987
50. BOELAERT JR, DANEELS RF, SCHURGERS ML, MATTHYS EG, GORDTS BZ, VAN LANDUYT HW: Iron overload in haemodialysis patients increases the risk of bacteraemia: A prospective study. Nephrol Dial Transplant 5:130-134, 1990
51. JENSEN PD, HEICKENDORFF L, PEDERSEN B, BENDIX-HANSEN K, JENSEN FT, CHRISTENSEN T, BOESEN AM, ELLEGAARD J: The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol 94:288-299, 1996
52. WATERLOT Y, CANTINIEAUX B, HARIGA-MULLER C, DE MAERTELAERE-LAURENT E, VANHERWEGHEM JL, FONDU P: Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: The critical role of iron overload. BMJ 291:501-504, 1985
53. FLAMENT J, GOLDMAN M, WATERLOT Y, DUPONT E, WYBRAN J, VANHERWEGHEM JL: Impairment of phagocyte oxidative metabolism in hemodialyzed patients with iron overload. Clin Nephrol 25:227-230, 1986
54. BOELAERT JR, CANTINIEAUX BF, HARIGA CF, FONDU PG: Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplant 5:504-507, 1990
55. BULLEN JJ, WARD CG, ROGERS HJ: The critical role of iron in some clinical infections. Eur J Clin Microbiol Infect Dis 10:613-617, 1991
56. HAAG-WEBER M, HABLE M, FIEDLER G, BLUM I, SCHOLLMEYER P, KREUSSER W, HÖRL WH: Alterations of polymorphonuclear leukocyte glycogen metabolism and glucose in dialysis patients. Am J Kidney Dis 27:562-568, 1991
57. VANHOLDER R, DE SMET R, WATERLOOS MA, VAN LANDSCHOOT N, VOGELEERE P, HOSTE E, RINGOIR S: Mechanisms of uremic inhibition of phagocyte reactive species production: Characterization of the role of p-cresol. Kidney Int 47:510-517, 1995
58. HAAG-WEBER M, HÖRL WH: The immune system in uremia and during its treatment. N Horiz 3:669-679, 1995
59. HÖRL WH: Neutrophil function and infections in uremia. Am J Kidney Dis (in press)
60. HOEPELMAN IM, JAARSMA EY, VERHOEF J, MARX JJM: Polynuclear iron complexes impair the function of polymorphonuclear granulocytes. Br J Haematol 68:385-389, 1988
61. VAN ASBECK BS, MARX JJM, STRUYVENBERG A, VAN KATS JH, VERHOEF J: Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes. J Immunol 132:851-856, 1984
62. VAS ASBECK BS, MARX JJ, STRUYVENBERG A, VAN KATS JH, VERHOEF J: Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes. Blood 63:714-720, 1984
63. DANCIS A, ROMAN DG, ANDERSON GJ, HINNEBUSCH AG, KLAUSNER RD: Ferric reductase of Saccharomyces cerevisiae: Molecular characterization, role in iron uptake, and transcriptional control by iron. Proc Natl Acad Sci USA 89:3869-3873, 1992
64. PATRUTA SI, EDLINGER R, SUNDER-PLASSMANN G, HÖRL WH: Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 9:655-663, 1998
65. CANTINIEAUX B, HARIGA C, FERSTER A, DE MAERTAELERE E, TOPPET M, FONDU P: Neutrophil dysfunctions in thalassaemia major: The role of cell iron overload. Eur J Haematol 39:28-34, 1987
66. CHATENOUD L, HERBELIN A, BEAURAIN G, DESCAMPS-LATSCHA B: Immune deficiency of the uremic patient. Adv Nephrol Necker Hosp 19:259-274, 1990
67. KRÖNKE M, LEONARD WJ, DEPPER JM, GREENE WC: Sequential expression of genes involved in human T lymphocyte growth and differentiation. J Exp Med 161:1593-1598, 1985
68. RUDD MJ, GOOD MF, CHAPMAN DE, POWELL LW, HALLIDAY JW: Clonal analysis of the effect of iron on human cytotoxic and proliferating T lymphocytes. Immunol Cell Biol 68:317-324, 1990
69. BROCX JH. DE SOUSA M: Immunoregulating by iron-binding proteins. Immunol Today 7:30-31, 1986
70. TAETLE R, HONEYSETT JM: Gamma-interferon modulates human monocyte/macrophage transferrin receptor expression. Blood 71:1590-1595, 1988
71. PELOSI-TESTA E, SAMOGGIA P, GIANELLA G, MONTESORO E, CARAVITA T, SALVO G, CAMAGNA A, ISACCHI G, TESTA U, PESCHLE C: Mechanisms underlying T-lymphocyte activation: Mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level. Immunology 64:273-279, 1988
72. DJEHA A, BROCK JH: Effect of transferrin, lactoferrin and chelated iron on human T-lymphocytes. Br J Haematol 80:235-241, 1992
73. RASKOVA J, GHOBRIAL I, CZERWINSKI DK, SHEA SM, EISINGER RP, RASKA K JR: B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis. Arch Intern Med 147:89-93, 1987
74. NECKERS LM, YENOKIDA G, JAMES SP: The role of the transferrin receptor in human B lymphocyte activation. J Immunol 133:2437-2441, 1984
75. PECES R, DE LA TORRE M, ALCÁZAR R, URRA JM: Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 29:239-245, 1997